The epidemiology of hepatitis a virus infection in children, in Edirne, Turkey

Turkey is a middle endemic area with respect to Hepatitis A virus (HAV) infection. However, the frequency of this infection varies due to socio-economic differences in various regions. The aim of this study was to detect the most likely age of exposure to HAV and factors affecting infection rates among children living in Edirne. A sample of 645 children between the ages of 0–19 living in Edirne were tested for total anti-HAV levels using ELISA method. A questionnaire on socio-economic status (SES), possible risk factors, and place of residence was completed for each child. Anti-HAV seropositivity was found to be 4.4, 25, 37.3 and 43.2%, in 2–5, 6–10, 11–14 and 15–19 age groups, respectively. Seropositivity was found to be increasing with age (p < 0.05). According to logistic regression analysis results; mother's education, SES of family, history of hepatitis in primary family members and the number of brothers or sisters were determined as factors increasing the seropositivity of HAV. Furthermore, HAV infection risk was found to be a decreasing function of income that is higher the income less likely the infection. These results showed that HAV infection rate in Edirne is in middle endemicity and the most likely way of exposure is transmission from family members. Although it requires further cost-effectiveness studies, our results indicate that applying the HAV vaccination in early childhood would be beneficial to decrease the prevalence of the infection and prevent HAV epidemics.

[1]  L. Koonin,et al.  Abortion surveillance--United States, 1991. , 1995, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.

[2]  L. Doğancı,et al.  Prevalence of hepatitis A, B and C in Turkey , 1992, European Journal of Clinical Microbiology and Infectious Diseases.

[3]  P. Más Lago,et al.  [Outbreaks of hepatitis A in the City of Havana in the year 1991]. , 1994, Revista cubana de medicina tropical.

[4]  M. CarmenMaroto,et al.  Hepatitis A virus , 1995 .

[5]  H. Margolis,et al.  The epidemiology of hepatitis B virus among family members in the Middle East. , 1990, American journal of epidemiology.

[6]  S. Felek,et al.  The Prevalence of Hepatitis A in the Elazig Region , 1996, Turkish Journal of Medical Sciences.

[7]  H. Tufenkeji Hepatitis A shifting epidemiology in the Middle East and Africa. , 2000, Vaccine.

[8]  A. Baki,et al.  Prevalence of antibody to hepatitis a virus among children in Trabzon, Turkey , 1993, Infection.

[9]  J. Geng,et al.  Assessing hepatitis A virus epidemic stochastic process in eight cities in China in 1990. , 1998, International journal of epidemiology.

[10]  John F. Modlin,et al.  Prevention of hepatitis A through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP) , 1996, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[11]  N. Barzaga,et al.  Hepatitis A shifting epidemiology in South-East Asia and China. , 2000, Vaccine.

[12]  B. Bell,et al.  Hepatitis A virus , 2016 .

[13]  J. Cianciara Hepatitis A shifting epidemiology in Poland and Eastern Europe. , 2000, Vaccine.

[14]  Hepatitis A vaccines WHO position paper , 2022 .

[15]  J. Tanaka,et al.  Hepatitis A shifting epidemiology in Latin America. , 2000, Vaccine.